Annual SGA
$45.48 M
+$14.35 M+46.12%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual SGA is $45.48 million, with the most recent change of +$14.35 million (+46.12%) on December 31, 2023.
- During the last 3 years, NMRA annual SGA has risen by +$37.08 million (+441.89%).
- NMRA annual SGA is now at all-time high.
Performance
NMRA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$16.02 M
+$822.00 K+5.41%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly SGA is $16.02 million, with the most recent change of +$822.00 thousand (+5.41%) on September 30, 2024.
- Over the past year, NMRA quarterly SGA has increased by +$1.70 million (+11.87%).
- NMRA quarterly SGA is now at all-time high.
Performance
NMRA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.16 B
-$293.70 M-10.23%
September 30, 2024
Summary
- As of February 7, 2025, NMRA TTM SGA is -$3.16 billion, with the most recent change of -$293.70 million (-10.23%) on September 30, 2024.
- Over the past year, NMRA TTM SGA has dropped by -$3.21 billion (-6415.92%).
- NMRA TTM SGA is now -3087.38% below its all-time high of -$99.29 million.
Performance
NMRA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NMRA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.1% | +11.9% | -6415.9% |
| 3 y3 years | +441.9% | +105.7% | -10000.0% |
| 5 y5 years | - | +105.7% | -10000.0% |
NMRA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.3% | at high | +122.6% | -389.7% | at low |
| 5 y | 5-year | at high | +441.9% | at high | +306.3% | -3087.4% | at low |
| alltime | all time | at high | +441.9% | at high | +306.3% | -3087.4% | at low |
Neumora Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.02 M(+5.4%) | $56.76 M(+1.3%) |
| Jun 2024 | - | $15.19 M(+6.1%) | $56.01 M(+11.8%) |
| Mar 2024 | - | $14.32 M(+27.4%) | $50.11 M(+10.2%) |
| Dec 2023 | $45.48 M(+46.1%) | $11.24 M(-26.4%) | $45.48 M(+9.8%) |
| Sep 2023 | - | $15.26 M(+64.2%) | $41.43 M(+21.1%) |
| Jun 2023 | - | $9.29 M(-4.0%) | $34.22 M(+4.6%) |
| Mar 2023 | - | $9.68 M(+34.6%) | $32.72 M(+5.1%) |
| Dec 2022 | $31.12 M | $7.20 M(-10.7%) | $31.12 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $8.05 M(+3.4%) | $31.56 M(+4.6%) |
| Jun 2022 | - | $7.79 M(-3.7%) | $30.17 M(+5.2%) |
| Mar 2022 | - | $8.09 M(+5.9%) | $28.69 M(+16.9%) |
| Dec 2021 | $24.55 M(+192.5%) | - | - |
| Dec 2021 | - | $7.64 M(+14.7%) | $24.55 M(+15.8%) |
| Sep 2021 | - | $6.66 M(+5.6%) | $21.20 M(+45.8%) |
| Jun 2021 | - | $6.31 M(+60.0%) | $14.54 M(+76.6%) |
| Mar 2021 | - | $3.94 M(-8.2%) | $8.24 M(+91.8%) |
| Dec 2020 | $8.39 M | $4.29 M | $4.29 M |
FAQ
- What is Neumora Therapeutics annual SGA?
- What is the all time high annual SGA for Neumora Therapeutics?
- What is Neumora Therapeutics annual SGA year-on-year change?
- What is Neumora Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly SGA year-on-year change?
- What is Neumora Therapeutics TTM SGA?
- What is the all time high TTM SGA for Neumora Therapeutics?
- What is Neumora Therapeutics TTM SGA year-on-year change?
What is Neumora Therapeutics annual SGA?
The current annual SGA of NMRA is $45.48 M
What is the all time high annual SGA for Neumora Therapeutics?
Neumora Therapeutics all-time high annual SGA is $45.48 M
What is Neumora Therapeutics annual SGA year-on-year change?
Over the past year, NMRA annual SGA has changed by +$14.35 M (+46.12%)
What is Neumora Therapeutics quarterly SGA?
The current quarterly SGA of NMRA is $16.02 M
What is the all time high quarterly SGA for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly SGA is $16.02 M
What is Neumora Therapeutics quarterly SGA year-on-year change?
Over the past year, NMRA quarterly SGA has changed by +$1.70 M (+11.87%)
What is Neumora Therapeutics TTM SGA?
The current TTM SGA of NMRA is -$3.16 B
What is the all time high TTM SGA for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM SGA is -$99.29 M
What is Neumora Therapeutics TTM SGA year-on-year change?
Over the past year, NMRA TTM SGA has changed by -$3.21 B (-6415.92%)